Three Companies That Could Be Priced Below Their Estimated Value In December 2024

As global markets navigate a period of mixed performance, with the Nasdaq Composite reaching new heights while other major indexes face declines, investors are keenly observing central bank actions and economic indicators that suggest potential shifts in monetary policy. Amidst these fluctuations, identifying stocks that may be undervalued can offer opportunities for those looking to capitalize on discrepancies between market price and intrinsic value. In this context, understanding what makes a stock potentially undervalued—such as strong fundamentals or market mispricing—becomes crucial for investors aiming to make informed decisions in an ever-changing economic landscape.

Advertisement

Top 10 Undervalued Stocks Based On Cash Flows

NameCurrent PriceFair Value (Est)Discount (Est)Shenzhen King Explorer Science and Technology (SZSE:002917)CN¥9.59CN¥19.1449.9%Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016)CN¥16.64CN¥33.1649.8%Xiamen Bank (SHSE:601187)CN¥5.68CN¥11.3550%MicroPort NeuroScientific (SEHK:2172)HK$9.18HK$18.2749.8%Management SolutionsLtd (TSE:7033)¥1701.00¥3400.0850%Absolent Air Care Group (OM:ABSO)SEK254.00SEK506.1849.8%BYD Electronic (International) (SEHK:285)HK$39.85HK$79.4549.8%Wetteri Oyj (HLSE:WETTERI)€0.297€0.5949.9%ReadyTech Holdings (ASX:RDY)A$3.13A$6.2650%ASMPT (SEHK:522)HK$75.95HK$150.9449.7%

Click here to see the full list of 906 stocks from our Undervalued Stocks Based On Cash Flows screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Hugel (KOSDAQ:A145020)

Overview: Hugel, Inc. is a biopharmaceutical company that develops and manufactures products in South Korea and internationally, with a market cap of ₩2.99 trillion.

Operations: The company's revenue segment includes pharmaceuticals, generating ₩363.79 billion.

Estimated Discount To Fair Value: 49.2%

Hugel is trading at ₩269,500, significantly below its estimated fair value of ₩530,453.69, indicating potential undervaluation based on cash flows. Earnings are expected to grow 22% annually, outpacing the South Korean market's 12.3%. Recent strategic moves include a share buyback program worth KRW 70 billion and a renewed distribution agreement in China for its Letybo product until 2030, enhancing shareholder value and market presence.

KOSDAQ:A145020 Discounted Cash Flow as at Dec 2024
KOSDAQ:A145020 Discounted Cash Flow as at Dec 2024

Duk San NeoluxLtd (KOSDAQ:A213420)

Overview: Duk San Neolux Co., Ltd is a South Korean company that develops and manufactures OLED materials for the display industry, with a market cap of ₩671.80 billion.

Operations: The company's revenue from the semiconductors segment is ₩205.55 billion.

Estimated Discount To Fair Value: 39.1%

Duk San Neolux Ltd. is trading at ₩28,800, significantly below its estimated fair value of ₩47,279.03, highlighting potential undervaluation based on cash flows. Earnings are projected to grow 22.4% annually over the next three years, surpassing the South Korean market's growth rate of 12.3%. Despite a low forecasted return on equity of 13.4%, robust revenue growth expectations and recent shareholder engagement reflect a promising outlook for investors focused on cash flow valuation metrics.

KOSDAQ:A213420 Discounted Cash Flow as at Dec 2024
KOSDAQ:A213420 Discounted Cash Flow as at Dec 2024

Anhui Anli Material Technology (SZSE:300218)

Overview: Anhui Anli Material Technology Co., Ltd. focuses on the R&D, production, sale, and servicing of ecological functional polyurethane synthetic leather products and other polymer composite materials in China with a market cap of CN¥3.57 billion.

Operations: The company generates revenue from its artificial leather synthetic leather industry segment, amounting to CN¥2.37 billion.

Estimated Discount To Fair Value: 22.5%

Anhui Anli Material Technology is trading at CN¥17.36, over 20% below its estimated fair value of CN¥22.39, suggesting potential undervaluation based on cash flows. The company reported a significant increase in net income to CNY 150.26 million for the first nine months of 2024, compared to CNY 41.63 million the previous year. Despite an unstable dividend track record and low forecasted return on equity of 17.3%, earnings are expected to grow significantly by 25.8% annually, outpacing the Chinese market's growth rate.

SZSE:300218 Discounted Cash Flow as at Dec 2024
SZSE:300218 Discounted Cash Flow as at Dec 2024

Seize The Opportunity

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About KOSDAQ:A213420

Duk San NeoluxLtd

Develops and manufactures OLED materials for display industry in South Korea.

Excellent balance sheet and fair value.

Advertisement

Weekly Picks

VA
valuebull
GOAI logo
valuebull on Eva Live ·

Is this the AI replacing marketing professionals?

Fair Value:US$7.4344.8% undervalued
27 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
ZA
PME logo
ZayaanS on Pro Medicus ·

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value:AU$196.7832.6% undervalued
29 users have followed this narrative
5 users have commented on this narrative
18 users have liked this narrative
ST
WBD logo
SteveGruber on Warner Bros. Discovery ·

The Rising Deal Risk That Helped Sink Netflix’s $72 Billion Bid for Warner Bros. Discovery  

Fair Value:US$18.1753.8% overvalued
5 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
PD
VRT logo
pdixit1 on Vertiv Holdings Co ·

The Infrastructure AI Cannot Be Built Without

Fair Value:US$408.6440.8% undervalued
33 users have followed this narrative
3 users have commented on this narrative
16 users have liked this narrative

Updated Narratives

KS
PME logo
ks3 on Pro Medicus ·

A stock I’m bullish on is Pro Medicus Limited (ASX: PME), an Australian healthcare technology company that develops medical imaging software

Fair Value:AU$199.733.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
KSS logo
Vestra on Kohl's ·

Kohl’s Corporation (KSS): The "Prestige-Value" Turnaround – Eyes on Tuesday’s Pre-Market Results.

Fair Value:US$19.5522.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VI
VNM logo
VietTrader on Vietnam Dairy Products ·

VNM: Market recovery expected, strong growth projected in 2026 with a target price of 76,800.

Fair Value:₫76.8k18.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.377.3% undervalued
50 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0229.7% undervalued
1100 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59631.4% undervalued
1297 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative